FDA provides accelerated approval of Talvey for multiple myeloma
The U.S. Food and Drug Administration has approved Talvey (talquetamab-tvgs) for patients with relapsed or refractory multiple myeloma.
Aug 16, 2023
0
1
The U.S. Food and Drug Administration has approved Talvey (talquetamab-tvgs) for patients with relapsed or refractory multiple myeloma.
Aug 16, 2023
0
1
Commercially available mass spectrometers can reliably detect the SARS-CoV-2 coronavirus. In the journal Clinical Proteomics, researchers from the Martin Luther University Halle-Wittenberg (MLU) present a new method which ...
Aug 16, 2023
0
43
The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related macular degeneration.
Aug 10, 2023
0
2
A multidisciplinary study led by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) presents a new method for assessing the structural and electrophysiological changes, called atrial remodeling, ...
Aug 4, 2023
0
73
For women with overactive bladder (OAB), percutaneous tibial nerve stimulation (PTNS) is associated with improvement of symptoms, according to a study published online May 16 in the Journal of Clinical Medicine.
Jun 29, 2023
0
2
A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich has discovered a novel anti-cancer drug called icFSP1, which sensitizes cancer cells to ferroptosis. The results of this research are published in Nature.
Jun 28, 2023
0
29
While people the world over enjoy a good laugh, remarkably little is known about this instinctive behaviour.
Jun 15, 2023
0
9
Children and young people naturally spend a large amount of their time at school, college or in other educational settings. And while most children with juvenile idiopathic arthritis (JIA) are able to access education, many ...
Jun 2, 2023
0
2
For patients with primary advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel increases progression-free survival versus carboplatin-paclitaxel alone, according to a study published online March ...
Apr 4, 2023
0
2
Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to a paper published in the New England Journal of ...
Mar 15, 2023
0
23